Norges Bank
BTTX

Norges Bank’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Norges Bank’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-597,015
Closed -$1.18M – 2192
2022
Q1 		$1.18M Buy
+597,015
New +$2.06M ﹤0.01% 2031

Other funds holding BTTX

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Norges Bank's BTTX Position: Q2 2022 in Review

Norges Bank sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q2 2022, closing a stake of 597,015 shares — an estimated $1.18M sold.

Norges Bank first reported a position in BTTX in Q1 2022 and held it in 1 quarter. The position peaked at $1.18M in Q1 2022. 14 funds tracked by Wall St. Rank hold BTTX as of Q2 2022.

  • Norges Bank reported no remaining Better Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Norges Bank sold 597,015 Better Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $1.18M.
  • Norges Bank first reported a position in Better Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Norges Bank's Better Therapeutics, Inc. Common Stock position peaked at $1.18M in Q1 2022.
  • 14 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.